| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |